Interactive Decision Support Tool

Smarter. Stronger. Together: Educating Providers and Patients to Optimize the Use of Targeted Oral Therapies for HR+/HER2- Breast Cancer

Gain perspectives on strategies for optimizing use of CDK4/6 and PI3K inhibitors for HR+/HER2- breast cancer, including discussion on effective patient education about these targeted oral therapies! Learn from the experts with downloadable slides, commentaries, podcast, on-demand Webcast, and an Interactive Decision Support Tool providing personalized management recommendations for adverse events associated with CDK4/6 and PI3K inhibitors.

Resources for your patients: https://www.smartpatients.com/resources/cco-breast-cancer

Donna M. Fitzgerald, PA-C, MPAS

Matthew P. Goetz, MD

Marissa Marti, APRN, AGNP-C, AOCNP

Joyce O'Shaughnessy, MD

Laura M. Spring, MD

Interactive Decision Support Tool

Decision Tool

An Interactive Tool for Managing AEs With Oral Targeted Therapies for HR+, HER2– Breast Cancer

View Decision Tool

Use this Interactive Decision Support Tool to learn strategies to assess and manage adverse events associated with oral targeted therapy for HR-positive, HER2-negative breast cancer from 5 experts.